277 related articles for article (PubMed ID: 33380808)
1. Targeting BRD9 for Cancer Treatment: A New Strategy.
Zhu X; Liao Y; Tang L
Onco Targets Ther; 2020; 13():13191-13200. PubMed ID: 33380808
[TBL] [Abstract][Full Text] [Related]
2. The ncBAF Complex Regulates Transcription in AML Through H3K27ac Sensing by BRD9.
Klein DC; Lardo SM; Hainer SJ
Cancer Res Commun; 2024 Jan; 4(1):237-252. PubMed ID: 38126767
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): Its therapeutic potential and selective inhibition.
Ali MM; Naz S; Ashraf S; Knapp S; Ul-Haq Z
Int J Biol Macromol; 2023 Mar; 230():123428. PubMed ID: 36709803
[TBL] [Abstract][Full Text] [Related]
4. [Understanding and therapeutic targeting of aberrant mRNA splicing mechanisms in oncogenesis].
Tanaka A; Kobayashi S; Xiao M; Inoue D
Rinsho Ketsueki; 2020; 61(6):643-650. PubMed ID: 32624538
[TBL] [Abstract][Full Text] [Related]
5. Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands.
Remillard D; Buckley DL; Paulk J; Brien GL; Sonnett M; Seo HS; Dastjerdi S; Wühr M; Dhe-Paganon S; Armstrong SA; Bradner JE
Angew Chem Int Ed Engl; 2017 May; 56(21):5738-5743. PubMed ID: 28418626
[TBL] [Abstract][Full Text] [Related]
6. BRD9 is a druggable component of interferon-stimulated gene expression and antiviral activity.
Börold J; Eletto D; Busnadiego I; Mair NK; Moritz E; Schiefer S; Schmidt N; Petric PP; Wong WW; Schwemmle M; Hale BG
EMBO Rep; 2021 Oct; 22(10):e52823. PubMed ID: 34397140
[TBL] [Abstract][Full Text] [Related]
7. BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming.
Sevinç K; Sevinç GG; Cavga AD; Philpott M; Kelekçi S; Can H; Cribbs AP; Yıldız AB; Yılmaz A; Ayar ES; Arabacı DH; Dunford JE; Ata D; Sigua LH; Qi J; Oppermann U; Onder TT
Stem Cell Reports; 2022 Dec; 17(12):2629-2642. PubMed ID: 36332631
[TBL] [Abstract][Full Text] [Related]
8. BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state.
Xiao M; Kondo S; Nomura M; Kato S; Nishimura K; Zang W; Zhang Y; Akashi T; Viny A; Shigehiro T; Ikawa T; Yamazaki H; Fukumoto M; Tanaka A; Hayashi Y; Koike Y; Aoyama Y; Ito H; Nishikawa H; Kitamura T; Kanai A; Yokoyama A; Fujiwara T; Goyama S; Noguchi H; Lee SC; Toyoda A; Hinohara K; Abdel-Wahab O; Inoue D
Nat Commun; 2023 Dec; 14(1):8372. PubMed ID: 38102116
[TBL] [Abstract][Full Text] [Related]
9. BRD9 regulates normal human hematopoietic stem cell function and lineage differentiation.
Garg S; Ni W; Chowdhury B; Weisberg EL; Sattler M; Griffin JD
Cell Death Differ; 2024 May; ():. PubMed ID: 38816579
[TBL] [Abstract][Full Text] [Related]
10. Research progress of selective small molecule bromodomain-containing protein 9 inhibitors.
Hui M; Jian Z; Peiyuan Z; Zhenwei W; Huibin Z
Future Med Chem; 2018 Apr; 10(8):895-906. PubMed ID: 29620420
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
[TBL] [Abstract][Full Text] [Related]
12. Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.
Theodoulou NH; Bamborough P; Bannister AJ; Becher I; Bit RA; Che KH; Chung CW; Dittmann A; Drewes G; Drewry DH; Gordon L; Grandi P; Leveridge M; Lindon M; Michon AM; Molnar J; Robson SC; Tomkinson NC; Kouzarides T; Prinjha RK; Humphreys PG
J Med Chem; 2016 Feb; 59(4):1425-39. PubMed ID: 25856009
[TBL] [Abstract][Full Text] [Related]
13. BRD9 is an essential regulator of glycolysis that creates an epigenetic vulnerability in colon adenocarcinoma.
Zhu Q; Gu X; Wei W; Wu Z; Gong F; Dong X
Cancer Med; 2023 Jan; 12(2):1572-1587. PubMed ID: 35778964
[TBL] [Abstract][Full Text] [Related]
14. Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells.
Yang Q; Vafaei S; Falahati A; Khosh A; Bariani MV; Omran MM; Bai T; Siblini H; Ali M; He C; Boyer TG; Al-Hendy A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255982
[TBL] [Abstract][Full Text] [Related]
15. BRD9 Inhibition by Natural Polyphenols Targets DNA Damage/Repair and Apoptosis in Human Colon Cancer Cells.
Kapoor S; Damiani E; Wang S; Dharmanand R; Tripathi C; Tovar Perez JE; Dashwood WM; Rajendran P; Dashwood RH
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297001
[TBL] [Abstract][Full Text] [Related]
16. BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma.
Weisberg E; Chowdhury B; Meng C; Case AE; Ni W; Garg S; Sattler M; Azab AK; Sun J; Muz B; Sanchez D; Toure A; Stone RM; Galinsky I; Winer E; Gleim S; Gkountela S; Kedves A; Harrington E; Abrams T; Zoller T; Vaupel A; Manley P; Faller M; Chung B; Chen X; Busenhart P; Stephan C; Calkins K; Bonenfant D; Thoma CR; Forrester W; Griffin JD
Blood Cancer J; 2022 Jul; 12(7):110. PubMed ID: 35853853
[TBL] [Abstract][Full Text] [Related]
17. Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells.
Zhou L; Yao Q; Li H; Chen J
Transl Cancer Res; 2021 Jul; 10(7):3364-3372. PubMed ID: 35116642
[TBL] [Abstract][Full Text] [Related]
18. Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma.
Chowdhury B; Garg S; Ni W; Sattler M; Sanchez D; Meng C; Akatsu T; Stone R; Forrester W; Harrington E; Buhrlage SJ; Griffin JD; Weisberg E
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610997
[TBL] [Abstract][Full Text] [Related]
19. BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition.
Del Gaudio N; Di Costanzo A; Liu NQ; Conte L; Migliaccio A; Vermeulen M; Martens JHA; Stunnenberg HG; Nebbioso A; Altucci L
Cell Death Dis; 2019 Apr; 10(5):338. PubMed ID: 31000698
[TBL] [Abstract][Full Text] [Related]
20. A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation.
Michel BC; D'Avino AR; Cassel SH; Mashtalir N; McKenzie ZM; McBride MJ; Valencia AM; Zhou Q; Bocker M; Soares LMM; Pan J; Remillard DI; Lareau CA; Zullow HJ; Fortoul N; Gray NS; Bradner JE; Chan HM; Kadoch C
Nat Cell Biol; 2018 Dec; 20(12):1410-1420. PubMed ID: 30397315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
